Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Background: Cladribine (2-CdA) can cross the blood–brain barrier, resulting in inhibition of DNA synthesis and repair and disruption of cellular proliferation in actively dividing lymphocytes. No data on effect on neurons are available. Aim: To study “in vitro” 2-CdA apoptotic effects on neurons in healthy donor and multiple sclerosis patient lymphocytes. Methods: Neuroblastoma cells were co-cultured with lymphocytes, with and without 2-CdA. Results: Apoptosis increased in lymphocytes with 2-CdA; increase was also observed when lymphocytes were cultured with neuronal cells. However, neurons were not affected by 2-CdA for apoptosis. Conclusions: 2-CdA causes peripheral and central lymphocyte death preserving neurons, with a reasonable impact on inflammation and neuroprotection.

Cite

CITATION STYLE

APA

Ruggieri, M., Gargano, C. D., Ferretta, A., Manni, A., Capacchione, A., Frigeri, A., … Paolicelli, D. (2020). Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy. Brain Sciences, 10(8), 1–13. https://doi.org/10.3390/brainsci10080548

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free